Mortgage-Backed Securities

Business

Orchid Island Capital Posts Stellar 2025 Earnings, Fueling Investor Optimism Amid Mortgage Market Shift

Orchid Island Capital, Inc. (NYSE:ORC) reported a dramatic surge in full-year 2025 net income, driven by a strategic expansion of its agency MBS portfolio and disciplined hedging. The results mark a potential inflection point for the mortgage REIT, reshaping its risk-reward profile after years of uneven performance.

Feb 2, 2026

Business

Orchid Island Capital Posts Strong Q4 on Favorable Rates, Strategic Portfolio Shift

Orchid Island Capital (ORC) reported robust fourth-quarter earnings, driven by a stable interest rate environment, tightening mortgage spreads, and lower funding costs. The REIT continued its strategic pivot into higher-coupon mortgage pools with built-in prepayment protection.

Jan 31, 2026

Business

Trump's Fed Nominee Kevin Warsh Champions Unconventional Path to Cheaper Mortgages

President Trump's pick to lead the Federal Reserve, former governor Kevin Warsh, advocates for a dramatic shift in central bank strategy—shrinking its balance sheet—as the key to lowering mortgage rates, a move that challenges prevailing economic orthodoxy.

Jan 30, 2026

Business

Analysts Revise Target for Invesco Mortgage Capital, Signaling Shift in Market Sentiment

A revised price target for Invesco Mortgage Capital (IVR) is prompting investors to reassess the mortgage REIT's trajectory amid evolving interest rate expectations and housing market dynamics.

Jan 30, 2026

Business

Jones Trading Upgrades ARMOUR Residential REIT to Buy, Sees Value Gap Versus Peers

ARMOUR Residential REIT (ARR) received a bullish upgrade from Jones Trading, which moved the stock to Buy with a $20.50 target, citing a discounted valuation and expected book value growth compared to agency mortgage REIT rivals.

Jan 30, 2026

Business

BTIG Upgrades Annaly Capital to 'Buy', Citing Dividend Appeal in Volatile Rate Environment

Analysts at BTIG have upgraded mortgage REIT Annaly Capital Management (NLY) from 'Neutral' to 'Buy', with a $25 price target, arguing the stock is positioned to benefit from dividend stability and potential spread movements in a turbulent interest rate landscape.

Jan 30, 2026

Business

Analyst Warns: Orchid Island Capital's Dividend Strategy May Hinder Book Value Growth

Compass Point initiates coverage on Orchid Island Capital (ORC) with a Neutral rating, citing concerns that the REIT's high dividend payouts could constrain its per-share book value appreciation despite its current undervaluation.

Jan 30, 2026

Business

Adamas Trust Gains Analyst Backing as Strategic Shift to Agency RMBS Fuels Optimism

B. Riley initiates coverage of Adamas Trust (ADAM) with a Buy rating and a $9 price target, citing the REIT's strategic portfolio pivot towards higher-quality Agency RMBS as a key driver for potential revaluation.

Jan 30, 2026

Business

Compass Point Raises Price Target on Invesco Mortgage Capital, Sees Opportunity in Wide Spreads

Analyst firm Compass Point reiterates its Buy rating on Invesco Mortgage Capital Inc. (IVR), increasing its price target to $9.50, citing attractive mortgage spreads as a key catalyst for the REIT's potential book value growth.

Jan 30, 2026

Business

AGNC Investment: A High-Yield mREIT Riding a Wave of Recovery

After a punishing period, AGNC Investment Corp. staged a remarkable comeback in 2025. With a 12% dividend yield and a more favorable macroeconomic backdrop, the mortgage REIT is attracting income investors. But is the momentum sustainable?

Jan 30, 2026

Business

PennyMac Mortgage Investment Trust Posts Strong Q4 on Securitization Surge, Navigates Production Headwinds

PennyMac Mortgage Investment Trust (PMT) closed 2025 with robust earnings, driven by a dramatic expansion in its private-label securitization business. While this growth fueled returns, the company's correspondent lending segment faced pressure, and faster mortgage prepayments impacted servicing rights income.

Jan 30, 2026

Business

Annaly Capital Posts Strong 2025 Finish, Citing Favorable Markets and Strategic Execution

Annaly Capital Management capped off a robust 2025 with a fourth-quarter economic return of 8.6%, driven by a constructive fixed-income environment and growth across its core strategies. The mortgage REIT highlighted conservative leverage, a secure dividend, and strategic capital deployment as it navigates evolving market conditions.

Jan 30, 2026

Business

PennyMac Mortgage Investment Trust Posts Strong Q4 Results, Eyes Growth in Non-Agency Market

PennyMac Mortgage Investment Trust (PMT) reported a robust fourth quarter, highlighted by a 13% return on equity and strategic advancements in its securitization business. Executives outlined a confident outlook for 2026, emphasizing disciplined risk management and growth in targeted lending segments.

Jan 30, 2026

Business

Palantir's AI Ambitions Fuel Analyst Optimism: Is It a Top Stock Pick for 2026?

As Palantir Technologies (PLTR) prepares to report Q4 2025 results, a wave of bullish analyst upgrades points to surging commercial demand for its AI platform, driving a debate over its valuation and long-term potential.

Feb 2, 2026

Business

Relay Therapeutics Gains Analyst Backing as Pipeline Shows Promise in Competitive Cancer Drug Landscape

Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.

Feb 2, 2026

Business

Microsoft's Recent Dip Presents Options Opportunity for Value Investors

As Microsoft shares trade nearly 12% below recent highs, some analysts see a buying opportunity. We explore how selling put options could offer investors a strategic entry point while generating income.

Feb 2, 2026

Business

Beta Bionics Faces FDA Warning Letter, Assures No Impact on Product Pipeline or Financials

The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.

Feb 2, 2026

Business

Global Sugar Glut Sends Prices Tumbling to Multi-Year Lows

Sugar futures extended their sharp decline this week, with London white sugar hitting a five-year low, as robust harvests from Brazil and India signal a prolonged period of ample global supplies.

Feb 2, 2026

Business

UBS Opens Door to Bitcoin and Ether for Select Wealth Clients in Cautious Crypto Foray

Swiss banking giant UBS is preparing to offer a limited group of its wealth management clients access to trade Bitcoin and Ether, marking a significant but measured step into digital assets as it responds to client demand and a shifting regulatory landscape.

Feb 2, 2026

Business

Nvidia at a Discount: Why the AI Titan Remains a Compelling Buy for 2026

Despite its status as the world's most valuable company, Nvidia's stock presents a surprising value proposition. With its GPUs powering the AI revolution, analysts see significant runway for growth well into 2026 and beyond.

Feb 2, 2026